Myriad Genetics IncNASDAQ:MYGN
- LAST PRICE15.1200
- TODAY'S CHANGE (%)-0.1800 (-1.1765%)
- Bid / Lots14.9700/ 3
- Ask / Lots15.4600/ 6
- Open / Previous Close15.3300 / 15.3000
- Day Range
- 52 Week Range
- Volume891,595
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MYGN |
|---|---|---|
| 09:32 ET | 5112 | 15.4945 |
| 09:33 ET | 1427 | 15.29 |
| 09:35 ET | 483 | 15.265 |
| 09:37 ET | 1622 | 15.26 |
| 09:39 ET | 5922 | 15.34 |
| 09:42 ET | 12505 | 15.4105 |
| 09:44 ET | 1100 | 15.4105 |
| 09:46 ET | 527 | 15.54 |
| 09:48 ET | 6128 | 15.39 |
| 09:50 ET | 300 | 15.45 |
| 09:51 ET | 5000 | 15.33 |
| 09:53 ET | 1166 | 15.31 |
| 09:55 ET | 927 | 15.31 |
| 09:57 ET | 586 | 15.34 |
| 10:00 ET | 17415 | 15.4 |
| 10:02 ET | 700 | 15.385 |
| 10:04 ET | 200 | 15.335 |
| 10:06 ET | 1552 | 15.29 |
| 10:08 ET | 5151 | 15.338773 |
| 10:09 ET | 133 | 15.341126 |
| 10:11 ET | 1390 | 15.389828 |
| 10:13 ET | 1388 | 15.4 |
| 10:15 ET | 2522 | 15.38 |
| 10:18 ET | 6764 | 15.435 |
| 10:20 ET | 7100 | 15.36 |
| 10:22 ET | 1426 | 15.44 |
| 10:24 ET | 566 | 15.395 |
| 10:26 ET | 100 | 15.395 |
| 10:27 ET | 1194 | 15.385 |
| 10:29 ET | 1155 | 15.37 |
| 10:31 ET | 800 | 15.34 |
| 10:33 ET | 901 | 15.336 |
| 10:36 ET | 1300 | 15.34 |
| 10:38 ET | 2491 | 15.369 |
| 10:40 ET | 500 | 15.355 |
| 10:42 ET | 2500 | 15.27 |
| 10:44 ET | 333 | 15.285 |
| 10:45 ET | 1218 | 15.32 |
| 10:47 ET | 605 | 15.34 |
| 10:49 ET | 967 | 15.36 |
| 10:51 ET | 311 | 15.35 |
| 10:54 ET | 500 | 15.38 |
| 10:56 ET | 1766 | 15.395 |
| 10:58 ET | 300 | 15.37 |
| 11:00 ET | 200 | 15.39 |
| 11:02 ET | 100 | 15.355 |
| 11:03 ET | 300 | 15.36 |
| 11:05 ET | 700 | 15.37 |
| 11:07 ET | 700 | 15.345 |
| 11:09 ET | 1000 | 15.33 |
| 11:12 ET | 700 | 15.3 |
| 11:14 ET | 400 | 15.27 |
| 11:16 ET | 4851 | 15.31 |
| 11:18 ET | 4622 | 15.3 |
| 11:20 ET | 1000 | 15.33 |
| 11:21 ET | 200 | 15.32 |
| 11:23 ET | 1000 | 15.345 |
| 11:25 ET | 200 | 15.32 |
| 11:27 ET | 300 | 15.34 |
| 11:30 ET | 900 | 15.31 |
| 11:32 ET | 800 | 15.32 |
| 11:34 ET | 700 | 15.33 |
| 11:36 ET | 2074 | 15.34 |
| 11:38 ET | 2425 | 15.28 |
| 11:39 ET | 1158 | 15.309186 |
| 11:41 ET | 300 | 15.25 |
| 11:43 ET | 400 | 15.26 |
| 11:45 ET | 100 | 15.275 |
| 11:48 ET | 400 | 15.28 |
| 11:50 ET | 992 | 15.275 |
| 11:52 ET | 300 | 15.275 |
| 11:54 ET | 100 | 15.26 |
| 11:56 ET | 4195 | 15.3 |
| 11:57 ET | 1477 | 15.325 |
| 11:59 ET | 100 | 15.33 |
| 12:01 ET | 1900 | 15.33 |
| 12:03 ET | 100 | 15.33 |
| 12:06 ET | 100 | 15.31 |
| 12:08 ET | 1281 | 15.311 |
| 12:10 ET | 1200 | 15.32 |
| 12:12 ET | 100 | 15.32 |
| 12:14 ET | 300 | 15.315 |
| 12:15 ET | 100 | 15.31 |
| 12:17 ET | 778 | 15.3 |
| 12:19 ET | 500 | 15.31 |
| 12:21 ET | 800 | 15.33 |
| 12:24 ET | 146 | 15.32 |
| 12:26 ET | 200 | 15.33 |
| 12:28 ET | 400 | 15.32 |
| 12:30 ET | 1403 | 15.33 |
| 12:32 ET | 1525 | 15.37 |
| 12:33 ET | 300 | 15.4 |
| 12:35 ET | 200 | 15.365 |
| 12:37 ET | 400 | 15.365 |
| 12:39 ET | 200 | 15.365 |
| 12:42 ET | 602 | 15.375 |
| 12:44 ET | 300 | 15.38 |
| 12:46 ET | 300 | 15.385 |
| 12:48 ET | 2284 | 15.34 |
| 12:50 ET | 100 | 15.34 |
| 12:51 ET | 1287 | 15.3 |
| 12:53 ET | 320 | 15.31 |
| 12:55 ET | 400 | 15.315 |
| 12:57 ET | 400 | 15.325 |
| 01:00 ET | 1320 | 15.3 |
| 01:02 ET | 1172 | 15.29 |
| 01:04 ET | 6591 | 15.245 |
| 01:06 ET | 400 | 15.225 |
| 01:08 ET | 100 | 15.23 |
| 01:09 ET | 756 | 15.25 |
| 01:11 ET | 800 | 15.25 |
| 01:13 ET | 579 | 15.25 |
| 01:15 ET | 400 | 15.255 |
| 01:18 ET | 200 | 15.255 |
| 01:20 ET | 1315 | 15.265 |
| 01:22 ET | 3183 | 15.225 |
| 01:24 ET | 649 | 15.25 |
| 01:26 ET | 2229 | 15.35 |
| 01:27 ET | 759 | 15.305 |
| 01:29 ET | 600 | 15.27 |
| 01:31 ET | 200 | 15.285 |
| 01:33 ET | 1183 | 15.295 |
| 01:36 ET | 282 | 15.27 |
| 01:38 ET | 896 | 15.32 |
| 01:40 ET | 300 | 15.32 |
| 01:42 ET | 183 | 15.2852 |
| 01:44 ET | 10089 | 15.23 |
| 01:45 ET | 805 | 15.28 |
| 01:49 ET | 1475 | 15.255 |
| 01:51 ET | 600 | 15.28 |
| 01:56 ET | 600 | 15.255 |
| 01:58 ET | 1287 | 15.251 |
| 02:00 ET | 633 | 15.255 |
| 02:02 ET | 200 | 15.255 |
| 02:03 ET | 100 | 15.26 |
| 02:05 ET | 1944 | 15.26 |
| 02:07 ET | 800 | 15.22 |
| 02:09 ET | 986 | 15.265 |
| 02:12 ET | 100 | 15.265 |
| 02:14 ET | 700 | 15.24 |
| 02:16 ET | 1002 | 15.23 |
| 02:18 ET | 1468 | 15.23 |
| 02:20 ET | 211 | 15.225 |
| 02:21 ET | 1320 | 15.175 |
| 02:23 ET | 1197 | 15.17 |
| 02:25 ET | 2263 | 15.18 |
| 02:27 ET | 1000 | 15.19 |
| 02:30 ET | 10928 | 15.06 |
| 02:32 ET | 3421 | 15.055 |
| 02:34 ET | 2271 | 15.05 |
| 02:36 ET | 1436 | 15.04 |
| 02:38 ET | 2701 | 15.035 |
| 02:39 ET | 767 | 15.035 |
| 02:41 ET | 1193 | 15.01 |
| 02:43 ET | 1410 | 15 |
| 02:45 ET | 3027 | 15.0067 |
| 02:48 ET | 1616 | 15.01 |
| 02:50 ET | 1000 | 14.99 |
| 02:52 ET | 1051 | 14.985 |
| 02:54 ET | 2153 | 14.945 |
| 02:56 ET | 12411 | 15 |
| 02:57 ET | 1002 | 15.01 |
| 02:59 ET | 1292 | 14.96 |
| 03:01 ET | 1433 | 14.98 |
| 03:03 ET | 821 | 14.975 |
| 03:06 ET | 1416 | 14.965 |
| 03:08 ET | 3639 | 15.005 |
| 03:10 ET | 1500 | 15.005 |
| 03:12 ET | 1900 | 15.015 |
| 03:14 ET | 2778 | 14.99 |
| 03:15 ET | 2117 | 14.99 |
| 03:17 ET | 1000 | 14.98 |
| 03:19 ET | 2315 | 15.02 |
| 03:21 ET | 800 | 15.015 |
| 03:24 ET | 692 | 15.02 |
| 03:26 ET | 1205 | 15.015 |
| 03:28 ET | 4991 | 15.06 |
| 03:30 ET | 1034 | 15.06 |
| 03:32 ET | 904 | 15.055 |
| 03:33 ET | 2163 | 15.06 |
| 03:35 ET | 2281 | 15.15 |
| 03:37 ET | 1682 | 15.11 |
| 03:39 ET | 4081 | 15.09 |
| 03:42 ET | 3246 | 15.13 |
| 03:44 ET | 1315 | 15.12 |
| 03:46 ET | 3238 | 15.12 |
| 03:48 ET | 5287 | 15.1448 |
| 03:50 ET | 4891 | 15.1666 |
| 03:51 ET | 7243 | 15.12 |
| 03:53 ET | 3706 | 15.15 |
| 03:55 ET | 4157 | 15.16 |
| 03:57 ET | 10156 | 15.15 |
| 04:00 ET | 143618 | 15.12 |
Nov 20, 2024
Nov 19, 2024
Myriad Genetics Announces Prequel(R) Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 18, 2024
Myriad Genetics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Myriad Genetics, Inc. (MYGN), from 10:43AM ET on Monday Nov 18, 2024 by Dow Jones
10:43AM ET on Monday Nov 18, 2024 by Dow JonesBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Shareholders to Learn More About the Investigation, from 10:01AM ET on Monday Nov 18, 2024 by Dow Jones
10:01AM ET on Monday Nov 18, 2024 by Dow JonesDJ Myriad Genetics Is Maintained at Equal-Weight by Morgan Stanley, from 8:35AM ET on Monday Nov 18, 2024 by Dow Jones
8:35AM ET on Monday Nov 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Myriad Genetics Inc | 1.4B | -11.6x | --- |
Alphatec Holdings Inc | 1.4B | -8.0x | --- |
10X Genomics Inc | 1.6B | -8.7x | --- |
STAAR Surgical Co | 1.3B | 60.8x | +31.52% |
Tandem Diabetes Care Inc | 2.0B | -15.8x | --- |
Artivion Inc | 1.1B | -1,195.3x | --- |
Company Information
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight, among others.
Contact Information
- Headquarters
- 322 North 2200 WestSALT LAKE CITY, UT, United States 84116
- Phone
- 801-584-3600
- Fax
- 801-584-3640
Executives
- Independent Chairman of the Board
- S. Louise Phanstiel
- President, Chief Executive Officer, Director
- Paul Diaz
- Chief Financial Officer
- Scott Leffler
- President, Chief Clinical Officer - Oncology
- George Daneker
- Chief Operating Officer
- Sam Raha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $823.6M |
Shares Outstanding | 91.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.30 |
Book Value | $8.71 |
P/E Ratio | -11.6x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
